-- 根據週四提交給新加坡交易所的文件，iX Biopharma（SGX：42C）已收到新加坡交易所的上市及報價通知，擬發行130萬股股票。 這家製藥和營養保健品公司的股價在周一的交易中飆升近11%。 文件補充道，該通知尚需獲得股東批准並符合交易所的上市要求。
Related Articles
Asia
NTPC Declares 100MW Solar Capacity at Ramagundam on Commercial Operation
NTPC (NSE:NTPC, BOM:532555) said 100 MW of capacity from its 176 MW solar photovoltaic project at Ramagundam, Telangana, has been declared on commercial operation, effective May 2, according to a Saturday filing on Indian bourses.Shares of the company increased nearly 1% in Monday's trade.This increased the total installed capacity of the NTPC group to 89,805 MW, while commercial capacity stands at 88,725 MW, the filing said.
$BOM:532555$NSE:NTPC
Equities
Magnora Wins 145-MW Data Center Projects in Norway
Magnora (MGN.OL) will establish two data centers in Norway, adding 145 megawatts to its gross portfolio.The first project involves a 95-megawatt data center in the country's southwestern region, according to a Monday release.The renewable energy group's remaining project, meanwhile, has a capacity of 50 megawatts and is located in the northwestern region of Norway.
$MGN.OL
Asia
National Aerospace Fasteners' Revenue Rises 21% in April
National Aerospace Fasteners (TPE:3004) logged consolidated revenue of NT$419 million in April, rising 20.7% from NT$348 million a year earlier.Monthly, revenue fell 7.37% from NT$453 million in March, according to a Monday Taiwan Exchange filing.For January to April, cumulative revenue climbed 26.5% annually to NT$1.623 billion, from NT$1.283 billion in the same period last year.
$TPE:3004